| Literature DB >> 28639379 |
Hina Gul1, Mushtaq Ahmad1, Muhammad Zafar1, Muhammad Sheeraz Ahmad2, Ambreen Abid2, Syeda Hira2, Imam Shah3, Muhammad Gulfraz4.
Abstract
The cape myrtle, Myrsine africana L., is a widely used medicinal plant, which has not been well investigated. We assessed the in vivo hepatoprotective and in vitro antiproliferative and antioxidant effects of leaf extracts of M. africana chemically profiled using high-performance liquid chromatography. Three flavonoids were quantified, and gas chromatography-mass spectrometry analysis revealed the presence of common fatty acids. The animal study was conducted on mice treated with CCl4, using three doses each of the methanol and chloroform extract (100, 200 and 300 mg/kg b.w.),with silymarin as a positive control. Hepatoprotective effects were determined by analyzing blood for liver marker and antioxidant enzymes, direct bilirubins and total proteins. The methanol extract (300 mg/kg b.w.) showed the strongest hepatoprotective effects against abnormalities produced by CCl4. The in vivo hepatoprotective effects correlated well with the in vitro antioxidant and antiproliferative activities and with high levels of flavonoids in the extracts. Finally, molecular docking studies of the constituent quercetin were undertaken in silico and several sites of binding to human estrogen receptor (ER) protein, linked with alkaline phosphatase, identified.Entities:
Keywords: Myrsine africana; antioxidant; antiproliferative; hepatoprotective; molecular docking; quercetin
Mesh:
Substances:
Year: 2017 PMID: 28639379 DOI: 10.1002/ptr.5853
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878